Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials

被引：0
|
作者：
Andrew M. Blumenfeld
Kerry Knievel
Aubrey Manack Adams
Lawrence Severt
Matthew Butler
Hongxin Lai
David W. Dodick
机构：
[1] Headache Center of Southern California,
[2] Barrow Neurological Institute,undefined
[3] AbbVie,undefined
[4] AbbVie,undefined
[5] Mayo Clinic,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Acute treatment; Concomitant therapies; Migraine; Preventive treatment; Ubrogepant;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：692 / 705
页数：13
相关论文
共 50 条
  • [31] Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
    Silberstein, Stephen D.
    Diener, Hans-Christoph
    Dodick, David W.
    Sommer, Katherine
    Lipton, Richard B.
    HEADACHE, 2024, 64 (07): : 838 - 848
  • [32] Bazedoxifene/Conjugated Estrogens in Minority Populations: Pooled Analysis of Phase 3 Trials
    Pinkerton, JoAnn V.
    Ryan, Kelly
    Messig, Michael
    Komm, Barry
    Pickar, James H.
    Mirkin, Sebastian
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (12): : 1347 - 1347
  • [33] Breast Safety of Bazedoxifene/Conjugated Estrogens: Pooled Analysis of Phase 3 Trials
    Pickar, James H.
    Ryan, Kelly
    Messig, Michael
    Komm, Barry
    Mirkin, Sebastian
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (12): : 1323 - 1323
  • [34] Orally Administered Atogepant Was Efficacious, Safe, and Tolerable for the Prevention of Migraine: Results from a Phase 2b/3 Study
    Goadsby, P. J.
    Dodick, D. W.
    Ailani, J.
    Trugman, J. M.
    Finnegan, M.
    Lakkis, H.
    Lu, K.
    Szegedi, A.
    HEADACHE, 2019, 59 : 18 - 19
  • [35] Orally Administered Atogepant Was Efficacious, Safe, and Tolerable for the Prevention of Migraine: Results From a Phase 2b/3 Study
    Goadsby, Peter J.
    Dodick, David W.
    Ailani, Jessica
    Trugman, Joel M.
    Finnegan, Michelle
    Lakkis, Hassan
    Lu, Kaifeng
    Szegedi, Armin
    CEPHALALGIA, 2019, 39 : 182 - 183
  • [36] Orally administered atogepant was efficacious, safe, and tolerable for the prevention of migraine: results from a phase 2b/3 study
    Goadsby, P. J.
    Dodick, D. W.
    Ailani, J.
    Trugman, J. M.
    Finnegan, M.
    Lakkis, H.
    Lu, K.
    Szegedi, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 811 - 811
  • [37] Orally Administered Atogepant Was Efficacious, Safe, and Tolerable for the Prevention of Migraine: Results From a Phase 2b/3 Study
    Goadsby, Peter J.
    Dodick, David W.
    Trugman, Joel M.
    Finnegan, Michelle
    Lakkis, Hassan
    Lu, Kaifeng
    Szegedi, Armin
    NEUROLOGY, 2019, 92 (15)
  • [38] Efficacy and Safety of Plecanatide in Patients With Chronic Idiopathic Constipation: Pooled Analysis of Two Phase 3 Trials Stratified by Concomitant Acid Suppression Use
    Moshiree, Baharak
    Schoenfeld, Philip S.
    Patel, Reema
    Lorenzen, Sarah
    Rezaie, Ali
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S252 - S253
  • [39] Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial
    Koichi Hirata
    Fumihiko Sakai
    Takao Takeshima
    Noboru Imai
    Yasuhiko Matsumori
    Ryuji Yoshida
    Yotaro Numachi
    Cheng Peng
    Daniel D. Mikol
    Sunfa Cheng
    The Journal of Headache and Pain, 2021, 22
  • [40] Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial
    Hirata, Koichi
    Sakai, Fumihiko
    Takeshima, Takao
    Imai, Noboru
    Matsumori, Yasuhiko
    Yoshida, Ryuji
    Numachi, Yotaro
    Peng, Cheng
    Mikol, Daniel D.
    Cheng, Sunfa
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
12345